Restructuring and Related Charges

6 Months Ended

Mar. 31, 2023

Restructuring and Related Activities [Abstract]

To better align its resources with its growth strategies and reduce its cost structure, the Company commits to various restructuring plans as necessary. The Company has undertaken various restructuring initiatives, including activities to reduce the cost structure and rationalize location footprint, realigning operating models designed to better serve the needs of customers worldwide, and various initiatives within the Integrated Solutions and Services segment to drive efficiency and effectiveness in certain divisions.

The Company currently expects to incur in future periods approximately $3,400 to $4,400 of costs related to restructuring programs initiated in prior periods.

The table below sets forth the amounts accrued for the restructuring components and related activity:


	Six Months Ended March 31,
	2023		2022
Balance at beginning of the period	$	658	$	304
Restructuring charges related to organizational realignment	1,768		987
Restructuring charges related to facility consolidation	589		1,874
Restructuring charges related to other initiatives	138		7
Release of prior reserves	(223)		(66)

Cash payments	(1,968)		(2,220)
Other adjustments	1		2
Balance at end of the period	$	963	$	888

The balances for accrued restructuring liabilities at March 31, 2023 and September 30, 2022, are recorded in Accrued expenses and other liabilities on the Consolidated Balance Sheets. Restructuring charges primarily represent severance charges and other employee costs, fixed asset write-offs, and certain relocation expenses. The Company expects to pay the remaining amounts accrued as of March 31, 2023 during the remainder of fiscal 2023.

The table below sets forth the location of amounts recorded above on the Unaudited Consolidated Statements of Operations:


	Six Months Ended March 31,
	2023		2022
Cost of product sales and services	$	910	$	867
General and administrative expense	1,010		1,719
Sales and marketing expense	282		—
Research and development expense	138		1
Other operating expense, net	(68)		215
	$	2,272	$	2,802

The Company continues to evaluate restructuring activities that may result in additional charges in the future.